How many biotech companies are there in Switzerland?
Table of Contents
How many biotech companies are there in Switzerland?
314
In the last ten years, the number of biotechs in Switzerland has grown from 236 in 2010 to 314 in 2020. Swiss biotechs employed more than 16,000 people in 2020. High-profile companies in Switzerland include CRISPR Therapeutics, ADC Therapeutics, AC Immune, Idorsia, and Basilea.
WHY IS pharma in Switzerland?
As a highly specialized production location for pharmaceutical products, Switzerland enjoys an excellent reputation the world over. Both multinational corporations and small and medium-sized pharmaceutical companies benefit from ideal infrastructure and well-trained professionals here.
Which country has the highest pharmaceutical industry?
The United States
The United States was the largest pharmaceutical market in 2020, generating roughly 46 percent of total revenues worldwide. China established itself as the second-largest market with a sales share of eight percent (altough the statistic shows the hospital market only for China).
Is Switzerland Good for biotech?
Switzerland is one of the best and most innovative locations for biotechnology in Europe. Local companies hold leading positions throughout many sectors and thus attract capital and researchers from all over the world. Switzerland offers an outstanding framework for procuring capital.
How many multinational companies are there in Switzerland?
The best available data indicates that there are roughly 25,500 foreign and Swiss multinationals in Switzerland, which is about 5% of the more than 580,000 registered companies (in French).
Which country has the most biotech companies?
The USA is the topmost country for biotechnology jobs. Biotech sales have hit $450 in 2016 and the leading 10 bio-pharma firms are centered in the US, including Johnson & Johnson, Amgen, Pfizer.
Where is the biotech hub?
Los Angeles and San Diego, California Aside from San Francisco, Los Angeles and San Diego are also some of the ideal cities for biotech companies. According to Biocom’s 2019 Economic Impact Report Databook, California is home to three biotech and pharmaceutical hubs – San Francisco Bay Area, San Diego, and Los Angeles.
